个人简介
博士毕业于北京大学第一医院泌尿外科，现任浙江大学医学院附属第一医院余杭院区泌尿外科主治医师，特聘副研究员，浙江大学医学院硕士生导师。
专业擅长
前列腺癌、肾癌、膀胱癌等泌尿系肿瘤微创手术及全程化管理以及前列腺增生、结石的微创治疗。
研究方向
临床研究方向为泌尿系肿瘤的腹腔镜微创手术治疗，达芬奇机器人、国产机器人、前列腺激光剜除等微创技术的进展。
基础研究方向为肾癌、膀胱癌的发生发展、肿瘤免疫、免疫治疗、复发防治等。
成果奖项：（近五年主要成果及奖励情况）
主持国家自然科学基金、浙江省自然科学基金各1项，以第一作者及通讯作者发表SCI论文20余篇。
近五年代表性论文：
1. Peng D, Yang W, Tang T, He A, Xu X, Jing T, Xia D: PLA2G7 promotes immune evasion of bladder cancer through the JAK-STAT-PDL1 axis. Cell death & disease 2025, 16(1):234.
2. Yang W, Liu T, Ying W, Lu M, Xia D, Tang T, Peng D: Suppression of ASNS expression by VHL-mediated ubiquitination hinders the progression of renal cell carcinoma through enhancing JUP expression and inhibiting PI3K-AKT and MAPK pathways. Int J Biol Sci 2026, 22(6):3048-3069.
3. Yang W, Li Y, Li Z, Jiang C, Deng X, Peng D: HSP90AA1 restrains clear cell renal cell carcinoma progression by promoting CADM1 expression and suppressing the PI3K-AKT pathway through interaction with FBXO7. Cell Death Discovery 2026, 12(1).
4. Yang W, Wu C, Jiang C, Jing T, Lu M, Xia D, Peng D: FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression. Cell Death Discov 2025, 11(1):115.
5. Yang W, Jing T, Wu C, Lu M, Yao X, Xia D, Peng D: F-box protein FBXO21 overexpression inhibits the proliferation and metastasis of clear cell renal cell carcinoma and is closely related to the CREB pathway and tumor immune cell infiltration. J Transl Med 2025, 23(1):335.
6. Ye S, Peng D, Zhu L, Zhu Y, He A, Jing T, Yao X, Wei S, Zhao Q, Chen J et al: 5G-remote radical prostatectomy under novel robotic systems: a prospective comparative cohort study with local surgeries. Prostate Cancer Prostatic Dis 2025.
7. Peng D, Jing T, Yao X, Ye S, Xu X, He A, Liang Z, Lai C, Qi H, Meng H et al: Preliminary Experience of Partial Nephrectomy Through a New Single-Port Surgical Robot System. J Endourol 2023, 37(5):535-541.
8. Jing T, Peng D, Yao X, Ye S, Zhao Q, Ni M, Shao J, Xu X, He A, Liang Z et al: Single-port robot-assisted radical prostatectomy with the novel Shurui single-port robotic surgical system. J Endourol 2023.
9. Peng D, He A, He S, Ge G, Wang S, Ci W, Li X, Xia D, Zhou L: Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma. Int J Biol Sci 2022, 18(3):995-1007.
社会任职
《中国泌尿外科和男科疾病诊断治疗指南》编写组秘书
